Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma
収録刊行物
-
- Annals of Hematology
-
Annals of Hematology 91 (2), 257-269, 2011-07-01
Springer Science and Business Media LLC